← Back to Search

Cementless Knee Replacement for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by DePuy Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject was diagnosed with NIDJD
Subject is male or female and between the ages of 22 and 80 years at the time of surgery, inclusive
Must not have
Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive TKA
The Subject is a woman who is pregnant or lactating
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery)
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two types of cementless TKA RP systems to see which results in better functional performance as measured by the KOOS questionnaire.

Who is the study for?
This trial is for men and women aged 22-80 who are not bedridden, can consent to the study, understand procedures, complete questionnaires in English or translations provided, diagnosed with non-inflammatory degenerative joint disease (NIDJD), and suitable for cementless knee replacement. Exclusions include recent participation in other trials, litigation involvement, inflammatory arthritis conditions, life expectancy under five years, pregnancy/lactation status among others.
What is being tested?
The ATTUNE Cementless Total Knee Arthroplasty (TKA) system's performance is being tested. Specifically looking at functional improvements two years after surgery using the KOOS questionnaire. It compares cruciate retaining rotating platform and posterior stabilized rotating platform configurations of the TKA system.
What are the potential side effects?
While specific side effects are not listed here for this surgical intervention trial involving a cementless knee prosthesis system like ATTUNE TKA RP systems generally may have risks including pain at the site of surgery, infection risk post-operation, blood clots formation potential in legs or lungs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a non-inflammatory joint disease.
Select...
I am between 22 and 80 years old.
Select...
I am not confined to bed.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have pain from my spine that spreads to the limb getting knee replacement.
Select...
I am currently pregnant or breastfeeding.
Select...
I have had surgery on my knee before, like a partial replacement or other specific procedures.
Select...
I am diagnosed with a muscular disorder like fibromyalgia and take prescription medication for it.
Select...
I have a condition like MS that affects my walking or ability to bear weight.
Select...
I have gout that is not managed by my current treatment.
Select...
I have a type of inflammatory arthritis like rheumatoid or psoriatic arthritis.
Select...
I have had an amputation on the opposite side of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient-reported Outcome: Knee Injury and Osteoarthritis Outcome Score Activities of Daily Living (KOOS ADL)
Secondary study objectives
Combination of Patient-reported and Clinical-reported Outcome: Knee Society 2011
Evaluate changes in femoral component and tibial component alignment
Implant fixation: Radiographic assessment of bone-implant interface performance
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ATTUNE Cementless RP TKAExperimental Treatment1 Intervention
Subjects will receive a cementless, rotating platform total knee arthroplasty
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cementless Total Knee Arthroplasty
2017
N/A
~90

Find a Location

Who is running the clinical trial?

DePuy OrthopaedicsLead Sponsor
80 Previous Clinical Trials
25,417 Total Patients Enrolled
45 Trials studying Osteoarthritis
10,491 Patients Enrolled for Osteoarthritis
Sukhjeet KaurStudy DirectorSponsor GmbH
1 Previous Clinical Trials
400 Total Patients Enrolled

Media Library

Cementless Total Knee Arthroplasty Clinical Trial Eligibility Overview. Trial Name: NCT02839850 — N/A
Osteoarthritis Research Study Groups: ATTUNE Cementless RP TKA
Osteoarthritis Clinical Trial 2023: Cementless Total Knee Arthroplasty Highlights & Side Effects. Trial Name: NCT02839850 — N/A
Cementless Total Knee Arthroplasty 2023 Treatment Timeline for Medical Study. Trial Name: NCT02839850 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT02839850 — N/A
~59 spots leftby Nov 2025